Metformin as an antitumor agent in cancer prevention and treatment.
about
Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-AnalysisMicroRNA, nutrition, and cancer preventionHyperglycemia as a risk factor for cancer progressionSystematic review: Preventive and therapeutic applications of metformin in liver diseaseLeucine signaling in the pathogenesis of type 2 diabetes and obesityMetformin intake associates with better cognitive function in patients with Huntington's disease.In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Berberine suppresses gero-conversion from cell cycle arrest to senescence.Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemiaPotential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingPersonalized therapy in endometrial cancer: challenges and opportunities.Metformin use is associated with better survival of diabetic patients with pancreatic cancerAntidiabetic drug metformin suppresses endotoxin-induced uveitis in ratsDietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet.Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cellsAntidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.Epidemiology of ovarian cancer: a review.AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.Epithelial cell polarity: what flies can teach us about cancer.Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma.Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin.
P2860
Q26765139-A4711471-AF96-4766-AD53-B0FD0036B37EQ27010206-A1CB9AE5-B3AC-49D0-8D47-41C19934E4E3Q27687614-66629948-72D5-4B9F-B720-8FF8BB1BEE88Q28085535-3FCE31D4-6159-4C79-AEE0-461DA3677207Q29543116-6B42B6D6-51F2-405C-88CA-349349F2C30AQ33817346-EEE74E17-06C8-4DEA-A84D-FC449F98C6F7Q33841800-6FE361DB-DEE1-4265-BABA-C3CBE9011D34Q34366519-E8BA05B6-3E60-4EE4-BAE3-780FBAE28743Q34428550-55AB3429-7FE6-4B62-A2B9-7AB50FFB67D7Q34567724-330C1CBB-2CB8-4EE8-9D12-2D377D2961B5Q35911350-A535C263-219A-4AF8-8BE7-2B55796194B3Q36053323-3442AE42-6821-4D58-805C-8BFFBC61B68BQ36077002-B34467B8-982F-4731-A6A4-9D08CEDDCC77Q36130010-744406DD-54F0-4B0F-AE38-63C4DEDBB6BBQ36334079-8C927F8E-E160-48BB-973A-E20F888B77C2Q37280136-13D10DAB-6477-423A-BBED-B5F36104E90FQ37474343-61782B64-1A96-44AB-9069-E51CE5D521C2Q37720438-B975B9C1-B878-439B-9573-7E3E53C83472Q37976243-C364E5BB-33ED-45D5-A191-7464D7391852Q38038639-5175068E-5F77-4D48-BEA2-B30AB28723C4Q38519928-CE2534C6-89F0-44C3-9BC3-5E6C61007C57Q38728567-1EF88546-D252-4FC7-86D5-3DB6D42E381CQ39510564-55897E81-DE1B-4EDB-BE30-0FA18DFD6FBBQ47128274-F04EEA12-343D-4BBD-A228-77875E45E80DQ51362450-79FE444B-75BF-46D7-84EE-7D7236474809
P2860
Metformin as an antitumor agent in cancer prevention and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin as an antitumor agent in cancer prevention and treatment.
@en
Metformin as an antitumor agent in cancer prevention and treatment.
@nl
type
label
Metformin as an antitumor agent in cancer prevention and treatment.
@en
Metformin as an antitumor agent in cancer prevention and treatment.
@nl
prefLabel
Metformin as an antitumor agent in cancer prevention and treatment.
@en
Metformin as an antitumor agent in cancer prevention and treatment.
@nl
P2860
P1433
P1476
Metformin as an antitumor agent in cancer prevention and treatment.
@en
P2093
Donghui Li
P2860
P304
P356
10.1111/J.1753-0407.2011.00119.X
P577
2011-12-01T00:00:00Z